Repeated profiles [Surveys]

posted by Helmut Homepage – Vienna, Austria, 2010-01-04 14:53 (5219 d 22:15 ago) – Posting: # 4556
Views: 12,287

Dear D. Labes,

thanks for participating!

❝ ❝ replicate design in steady state (i.e., TTRR-RRTT)

                                            ^^^^  :ponder:


Something like this:
saturation phase     T       T     switch over         R       R
saturation phase     R       R     switch over         T       T
pre dose values   profile profile  pre dose values  profile profile


This is my interpretation of EMA’s MR-NfG (Section 4.1.2):

The inter-individual variability of the pharmacokinetic parameters of interest should be compared between the modified and immediate release formulation and the variability of the modified release formulation should not exceed that of the immediate release formulation. It may be valuable to assess the intra-individual variability. This could be achieved by either repeated measurements of the concentration profile at steady state or by performing a single dose study with replicate design.

(my emphasis)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,656 registered users;
104 visitors (0 registered, 104 guests [including 6 identified bots]).
Forum time: 14:09 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5